(Q47948456)

7 February 2018

title

Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients (English)

1 reference

7 February 2018

author name string

Mirza Masroor

1 reference

7 February 2018

Jamsheed Javid

1 reference

7 February 2018

Rashid Mir

1 reference

7 February 2018

Prasant Y

1 reference

7 February 2018

Imtiyaz A

1 reference

7 February 2018

Mariyam Z

1 reference

7 February 2018

Anant Mohan

1 reference

7 February 2018

P C Ray

1 reference

7 February 2018

Alpana Saxena

1 reference

7 February 2018

publication date

9 August 2015

1 reference

7 February 2018

published in

Tumor Biology

1 reference

7 February 2018

volume

1 reference

7 February 2018

issue

1 reference

7 February 2018

page(s)

857-863

1 reference

7 February 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

ErbB receptors and signaling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Analysis of ErbB receptors in pulmonary carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Prognostic value of ERBB family mRNA expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Expression and differential signaling of heregulins in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

ErbB-4: mechanism of action and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3859-3

Detection of amplifiable messenger RNA in the serum of patients with lung cancer.

21 January 2018

1 reference

12 December 2020

HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test

1 reference

12 December 2020

Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

1 reference

12 December 2020

Telomerase RNA as a detection marker in the serum of breast cancer patients

1 reference

12 December 2020

Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma.

1 reference

12 December 2020

Detection of tumor messenger RNA in the serum of patients with malignant melanoma

1 reference

12 December 2020

Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer.

1 reference

12 December 2020

Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas

1 reference

12 December 2020

Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma.

1 reference

12 December 2020

Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients

1 reference

12 December 2020

Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers

1 reference

12 December 2020

Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin alpha in human normal bronchial epithelial and lung cancer cell lines.

1 reference

12 December 2020

Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression

1 reference

12 December 2020

Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay

1 reference

12 December 2020

Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis

1 reference

12 December 2020

ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases

1 reference

12 December 2020

A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples

1 reference

12 December 2020

10.1007/S13277-015-3859-3

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018